Bio-Techne is a U.S.-based company established in 1976, operating within the Business Services sector, specifically focusing on research and development in life sciences manufacturing, biotechnology, and pharmaceuticals. The company employs between 1,001 and 5,000 individuals and generates significant revenue, reflecting its established presence in the industry. Bio-Techne specializes in advanced analytical techniques for protein characterization, as evidenced by its published document discussing the advantages of capillary electrophoresis-sodium dodecyl sulfate (CE-SDS) over traditional SDS-PAGE methods. The document highlights the precision, quantitation, and automation benefits of CE-SDS, which is particularly relevant for biopharmaceutical applications involving biotherapeutics. The analysis indicates that CE-SDS offers superior resolution and reproducibility, making it suitable for regulated environments. Bio-Techne's commitment to innovation in biotechnological methods is evident in its focus on streamlining protein analysis workflows, thereby reducing variability and improving data accuracy. The company's expertise positions it as a key player in the life sciences and biotechnology sectors.